- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07287982
En studie for å vurdere sikkerhet, tolerabilitet, effekt, farmakokinetikk og immunogenisitet ved intravenøs administrering av ARGX-119 til pediatriske deltakere i alderen 5 til under 18 år med spinal muskelatrofi (Sparkle)
En fase 2 dobbeltblind, randomisert, placebokontrollert studie for å vurdere sikkerhet, tolerabilitet, effekt, farmakokinetikk og immunogenisitet ved intravenøs administrasjon av ARGX-119 hos pediatriske deltakere i alderen 5 til under 18 år med spinal muskelatrofi
This study aims to find the correct dose of ARGX-119 for children with SMA. The study will also look at how safe the study drug is, how well it works, how it moves through the body, and how the immune system responds to it. The study consists of a double-blinded treatment period (DBTP) where participants will either receive ARGX-119 IV or placebo IV, in addition to disease-modifying therapy (DMT) for 24 weeks. Participants who complete the DBTP will enter the open-label active-treatment extension period (ATEP) during which all participants will receive ARGX-119 IV up to 100 weeks (approximately 2 years).
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This phase 2 study aims to establish proof of concept with the age-appropriate dose of ARGX-119 in ambulant pediatric patients with spinal muscular atrophy (SMA). Despite available treatments, there remains an unmet medical need for patients with SMA. Neuromuscular junction (NMJ) dysfunction contributes to the pathophysiology of SMA, including muscle weakness and fatigability. Activation of muscle-specific kinase (MuSK) by ARGX-119 may stabilize and improve NMJ function in patients with SMA, reducing muscle weakness and fatigability, and improving quality of life.
Studietype
Registrering (Antatt)
Fase
- Fase 2
Kontakter og plasseringer
Studiekontakt
- Navn: Sabine Coppieters, MD
- Telefonnummer: 857-350-4834
- E-post: Clinicaltrials@argenx.com
Studiesteder
-
-
New South Wales
-
Randwick, New South Wales, Australia, 2031
- Rekruttering
- Sydney Children's Hospital, Randwick
-
Hovedetterforsker:
- Michelle Farrar
-
Ta kontakt med:
- Michelle Farrar
- Telefonnummer: 61293821549
- E-post: michelle.farrar@health.nsw.gov.au
-
-
Victoria
-
Parkville, Victoria, Australia, 3052
- Har ikke rekruttert ennå
- Royal Children's Hospital
-
Ta kontakt med:
- Eppie Yiu
- Telefonnummer: +61412599077
- E-post: eppie.yiu@rch.org.au
-
Hovedetterforsker:
- Eppie Yiu
-
-
-
-
-
Ghent, Belgia, 9000
- Har ikke rekruttert ennå
- Universitair Ziekenhuis Gent
-
Hovedetterforsker:
- Nicolas Deconinck
-
Ta kontakt med:
- Nicolas Deconinck
- Telefonnummer: +3293321954
- E-post: nicolas.deconinck@huderf.be
-
Leuven, Belgia, 3000
- Har ikke rekruttert ennå
- UZ Leuven
-
Hovedetterforsker:
- Liesbeth De Waele
-
Ta kontakt med:
- Liesbeth De Waele
- Telefonnummer: +3216340610
- E-post: liesbeth.dewaele@uzleuven.be
-
Liège, Belgia, 4000
- Har ikke rekruttert ennå
- C. H. R. de la Citadelle
-
Hovedetterforsker:
- Aurore Daron
-
Ta kontakt med:
- Aurore Daron
- Telefonnummer: +3242238515
- E-post: aurore.daron@chrcitadelle.be
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T3B 6A*
- Har ikke rekruttert ennå
- University of Calgary - Alberta Children's Hospital
-
Hovedetterforsker:
- Jean Mah
-
Ta kontakt med:
- Jean Mah
- Telefonnummer: 4039557816
- E-post: jean.mah@albertahealthservices.ca
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3V4
- Har ikke rekruttert ennå
- BC Children's Hospital
-
Hovedetterforsker:
- Kathryn Selby
-
Ta kontakt med:
- Kathryn Selby
- Telefonnummer: 60487523452121
- E-post: kselby@cw.bc.ca
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Tilbaketrukket
- The Hospital for Sick Children
-
-
-
-
Arkansas
-
Little Rock, Arkansas, Forente stater, 72202
- Rekruttering
- Arkansas Children's Hospital
-
Ta kontakt med:
- Steven Giompoletti
- Telefonnummer: (501) 364-1430
- E-post: giompolettis@archildrens.org
-
Hovedetterforsker:
- Kapil Arya, Dr.
-
-
California
-
San Diego, California, Forente stater, 92123
- Tilbaketrukket
- Rady Childrens Hospital
-
Stanford, California, Forente stater, 94305
- Rekruttering
- Stanford University Medical Center
-
Ta kontakt med:
- Lidia Choniawko
- Telefonnummer: (650) 304-8094
- E-post: lidiacho@stanford.edu
-
Hovedetterforsker:
- Carolina Tesi Rocha, Dr.
-
-
Connecticut
-
Hartford, Connecticut, Forente stater, 06106
- Rekruttering
- Connecticut Children's Medical Center
-
Ta kontakt med:
- Gyula Acsadi
- Telefonnummer: (860) 545-9460
- E-post: gacsadi@connecticutchildrens.org
-
Hovedetterforsker:
- Gyula Acsadi, Dr.
-
-
Florida
-
Kissimmee, Florida, Forente stater, 34746
- Rekruttering
- Rare Disease Research FL LLC
-
Ta kontakt med:
- Maria Cordero
- Telefonnummer: (407) 545-7610
- E-post: maria.cordero@rarediseaseresearch.com
-
Hovedetterforsker:
- Renata Shih, Dr.
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Rekruttering
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
Ta kontakt med:
- Alka Maheshwari
- Telefonnummer: (815) 444-6362
- E-post: amaheshwari@luriechildrens.org
-
Hovedetterforsker:
- Nancy Kuntz, Dr.
-
-
Iowa
-
Iowa City, Iowa, Forente stater, 52242
- Rekruttering
- University of Iowa Stead Family Children's Hospital
-
Ta kontakt med:
- Katherine Mathews
- Telefonnummer: (319) 356-1851
- E-post: katherine-mathews@uiowa.edu
-
Hovedetterforsker:
- Katherine Mathews, Dr.
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21205
- Rekruttering
- The Johns Hopkins Hospital
-
Ta kontakt med:
- Jessica Nance
- Telefonnummer: (410) 955-4259
- E-post: jnance6@jhmi.edu
-
Hovedetterforsker:
- Jessica Nance, Dr.
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02115
- Rekruttering
- Boston Children's Hospital
-
Ta kontakt med:
- Samantha Remis
- Telefonnummer: (617) 355-2752
- E-post: samantha.remis@childrens.harvard.edu
-
Hovedetterforsker:
- Basil Darras, Dr.
-
-
Missouri
-
Columbia, Missouri, Forente stater, 65212
- Rekruttering
- The Curators of the University of Missouri on behalf of University of Missouri Health Care
-
Ta kontakt med:
- Heather McHatton
- Telefonnummer: (573) 882-7619
- E-post: heathermchatton@health.missouri.edu
-
Hovedetterforsker:
- Jane Emerson, Dr.
-
-
New York
-
New York, New York, Forente stater, 10032
- Rekruttering
- Columbia University Herbert Irving Comprehensive Cancer Center
-
Ta kontakt med:
- Claudia Chiriboga
- Telefonnummer: (646) 426-3876
- E-post: cac3@cumc.columbia.edu
-
Hovedetterforsker:
- Claudia Chiriboga, Dr.
-
-
North Carolina
-
Hillsborough, North Carolina, Forente stater, 27278
- Rekruttering
- Rare Disease Research NC, LLC
-
Ta kontakt med:
- Norma Davis
- Telefonnummer: (470) 665-3051
- E-post: norma.davis@rarediseaseresearch.com
-
Hovedetterforsker:
- Edward Smith, Dr.
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Har ikke rekruttert ennå
- Children's Hospital Philadelphia - Neurology
-
Ta kontakt med:
- Karen Monono
- Telefonnummer: (267) 425-0158
- E-post: mononok@chop.edu
-
Hovedetterforsker:
- John Brandsema, Dr.
-
-
Texas
-
Flower Mound, Texas, Forente stater, 75028
- Rekruttering
- Neurology Rare Disease Center
-
Hovedetterforsker:
- Diana Castro, Dr.
-
Ta kontakt med:
- Natalie Gomez
- Telefonnummer: (972) 999-1011
- E-post: Natalie.Gomez@Neuromdcenter.com
-
Houston, Texas, Forente stater, 77030
- Rekruttering
- Texas Children's Hospital
-
Ta kontakt med:
- Timothy Lotze
- Telefonnummer: (832) 822-1779
- E-post: tlotze@bcm.edu
-
Hovedetterforsker:
- Timothy Lotze, Dr.
-
-
Virginia
-
Norfolk, Virginia, Forente stater, 23507
- Har ikke rekruttert ennå
- Childrens Hospital of The Kings Daughters
-
Ta kontakt med:
- Crystal Proud
- Telefonnummer: (757) 668-9920
- E-post: crystal.proud@chkd.org
-
Hovedetterforsker:
- Crystal Proud, Dr.
-
-
-
-
-
Genova, Italia, 16147
- Har ikke rekruttert ennå
- Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS
-
Hovedetterforsker:
- Claudio Bruno
-
Ta kontakt med:
- Claudio Bruno
- Telefonnummer: +391056362620
- E-post: claudiobruno@gaslini.org
-
Messina, Italia, 98124
- Har ikke rekruttert ennå
- Azienda Ospedaliera Universitaria Policlinico G. Martino
-
Ta kontakt med:
- Sonia Messina
- Telefonnummer: +39902217191
- E-post: smessina@unime.it
-
Hovedetterforsker:
- Sonia Messina
-
Milan, Italia, 20133
- Har ikke rekruttert ennå
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
Hovedetterforsker:
- Riccardo Masson
-
Ta kontakt med:
- Riccardo Masson
- Telefonnummer: +39223942371
- E-post: riccardo.masson@istituto-besta.it
-
Roma, Italia, 00168
- Har ikke rekruttert ennå
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
-
Ta kontakt med:
- Eugenio Mercuri
- Telefonnummer: +39630155586
- E-post: mercuri.trial@policlinicogemelli.it
-
Hovedetterforsker:
- Eugenio Mercuri
-
-
Milano
-
Milan, Milano, Italia, 20162
- Har ikke rekruttert ennå
- Fondazione Serena Onlus - Centro Clinico Nemo
-
Hovedetterforsker:
- Emilio Albamonte
-
Ta kontakt med:
- Emilio Albamonte
- Telefonnummer: +3929143371
- E-post: emilio.albamonte@centrocliniconemo.it
-
-
-
-
-
Utrecht, Nederland, 3584-CX
- Har ikke rekruttert ennå
- UMC Utrecht
-
Hovedetterforsker:
- Ludo Van der Pol
-
Ta kontakt med:
- Ludo Van der Pol
- Telefonnummer: +318875551166
- E-post: w.l.vanderpol@umcutrecht.nl
-
-
-
-
-
Lodz, Polen, 93-338
- Har ikke rekruttert ennå
- Instytut Centrum Zdrowia Matki Polki
-
Hovedetterforsker:
- Lukasz Przyslo
-
Ta kontakt med:
- Lukasz Przyslo
- Telefonnummer: +48422711371
- E-post: lukasz.przyslo@iczmp.edu.pl
-
Poznan, Polen, 60-355
- Har ikke rekruttert ennå
- Uniwersytecki Szpital Kliniczny w Poznaniu
-
Hovedetterforsker:
- Barbara Steinborn
-
Ta kontakt med:
- Barbara Steinborn
- Telefonnummer: +48618691255
- E-post: bstein@ump.edu.pl
-
Warsaw, Polen, 02-091
- Har ikke rekruttert ennå
- Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
-
Hovedetterforsker:
- Anna Kostera Pruszczyk
-
Ta kontakt med:
- Anna Kostera Pruszczyk
- Telefonnummer: +48225992985
- E-post: anna.kostera-pruszczyk@wum.edu.pl
-
-
-
-
-
Barcelona, Spania, 08035
- Har ikke rekruttert ennå
- Hospital Universitari Vall d'Hebron - VHIR
-
Ta kontakt med:
- Laura Costa Comellas
- Telefonnummer: +34934893156
- E-post: lauracc89@gmail.com
-
Hovedetterforsker:
- Laura Costa Comellas
-
Valencia, Spania, 46026
- Har ikke rekruttert ennå
- Hospital Universitari i Politecnic La Fe
-
Hovedetterforsker:
- Inmaculada Pitarch Castellano
-
Ta kontakt med:
- Inmaculada Pitarch Castellano
- Telefonnummer: +34687450013
- E-post: inmapitarch@hotmail.com
-
-
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, Storbritannia, CB2 0QQ
- Rekruttering
- Addenbrooke's Hospital
-
Ta kontakt med:
- Deepa Krishnakumar
- Telefonnummer: +4412232451514
- E-post: deepa.krishnakumar@nhs.net
-
Hovedetterforsker:
- Deepa Krishnakumar
-
-
Greater London
-
London, Greater London, Storbritannia, WC1N 3JH
- Rekruttering
- Great Ormond Street Hospital for Children
-
Hovedetterforsker:
- Mariacristina Scoto
-
Ta kontakt med:
- Mariacristina Scoto
- Telefonnummer: +442079052639
- E-post: mariacristina.scoto@gosh.nhs.uk
-
-
Oxfordshire
-
Oxford, Oxfordshire, Storbritannia, OX3 9DU
- Rekruttering
- MDUK Oxford Neuromuscular Centre
-
Hovedetterforsker:
- Laurent Servais
-
Ta kontakt med:
- Laurent Servais
- Telefonnummer: +441865741166
- E-post: laurent.servais@paediatrics.ox.ac.uk
-
-
South Yorkshire
-
Sheffield, South Yorkshire, Storbritannia, S10 2TH
- Rekruttering
- Sheffield Children's Hospital
-
Hovedetterforsker:
- Min Ong
-
Ta kontakt med:
- Min Ong
- Telefonnummer: +441142717000
- E-post: min.ong@nhs.net
-
-
Strathclyde
-
Glasgow, Strathclyde, Storbritannia, G51 4TF
- Rekruttering
- Royal Hospital for Children
-
Ta kontakt med:
- Shuko Joseph
- Telefonnummer: +441414516527
- E-post: shuko.joseph2@nhs.scot
-
Hovedetterforsker:
- Shuko Joseph
-
-
West Midlands
-
Birmingham, West Midlands, Storbritannia, B9 5SS
- Rekruttering
- Birmingham Heartlands Hospital
-
Ta kontakt med:
- Deepak Parasuraman
- Telefonnummer: +441384456111
- E-post: deepak.parasuraman@uhb.nhs.uk
-
Hovedetterforsker:
- Deepak Parasuraman
-
-
West Yorkshire
-
Leeds, West Yorkshire, Storbritannia, LS1 3EX
- Rekruttering
- Leeds General Infirmary
-
Hovedetterforsker:
- Anne-Marie Childs
-
Ta kontakt med:
- Anne-Marie Childs
- Telefonnummer: +441133923113
- E-post: anne-marie.childs@nhs.net
-
-
-
-
-
Essen, Tyskland, 45147
- Har ikke rekruttert ennå
- Universitaetsklinikum Essen
-
Hovedetterforsker:
- Heike Koelbel
-
Ta kontakt med:
- Heike Koelbel
- Telefonnummer: +492017232508
- E-post: heike.koelbel@uk-essen.de
-
-
Baden-Wurttemberg
-
Freiburg im Breisgau, Baden-Wurttemberg, Tyskland, 79106
- Har ikke rekruttert ennå
- Universitaetsklinikum Freiburg
-
Hovedetterforsker:
- Astrid Pechmann
-
Ta kontakt med:
- Astrid Pechmann
- Telefonnummer: +4976127043951
- E-post: astrid.pechmann@uniklinik-freiburg.de
-
Ulm, Baden-Wurttemberg, Tyskland, 89075
- Har ikke rekruttert ennå
- Universitaetsklinikum Ulm
-
Ta kontakt med:
- Sebahattin Cirak
- Telefonnummer: +4973150057010
- E-post: sebahattin.cirak@uniklinik-ulm.de
-
Hovedetterforsker:
- Sebahattin Cirak
-
-
Bavaria
-
München, Bavaria, Tyskland, 80337
- Har ikke rekruttert ennå
- Klinikum der Universitaet Muenchen
-
Ta kontakt med:
- Astrid Blaschek
- Telefonnummer: +4989440055110
- E-post: astrid.blaschek@med.uni-muenchen.de
-
Hovedetterforsker:
- Astrid Blaschek
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Is aged ≥5 to <18 years when completing the informed consent process, defined as providing informed assent according to local regulations and having a parent or guardian sign the ICF, and can comply with protocol
- requirements.
- Has documented historical genetic diagnosis of 5q-SMA.
- Currently receiving a stable SMA treatment regimen (nusinersen or risdiplam) and/or have a history of onasemnogene abeparvovec treatment
- Must be able to walk at least 50 meters without walking aids in the 6MWT at screening
Exclusion Criteria:
- Known medical condition that would interfere with an accurate assessment of SMA, confound the results of the study, or put the participant at undue risk, as assessed by the investigator
- Recent major surgery, except spinal fusion, within 3 months of screening or intends to have major surgery during the study
- Current or previous administration of antimyostatin therapies in the past 6 months
- Severe scoliosis (defined as curvature >40°) and/or contractures at screening. o History of spinal fusion within 6 months before screening or planned during the study
- Respiratory insufficiency, defined by the medical necessity for invasive or noninvasive ventilation for daytime treatment while awake. Ventilation used overnight or during daytime naps is acceptable.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: DBTP - ARGX-119 IV
Participants receive ARGX-119 IV during the DBTP |
Intravenous infusion of ARGX-119 |
|
Placebo komparator: DBTP - Placebo IV
Participants receive placebo IV during the DBTP |
Intravenous infusion of placebo |
|
Placebo komparator: ATEP - ARGX-119 IV
Participants receive ARGX-119 IV during the ATEP. Participants from ARGX-119 IV arm in the DBTP will receive placebo once to maintain the DBTP blinding |
Intravenous infusion of placebo Intravenous infusion of ARGX-119 |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of AEs
Tidsramme: Up to 124 weeks
|
Adverse Events |
Up to 124 weeks
|
|
Incidence of SAEs
Tidsramme: Up to 124 weeks
|
Serious Adverse Events |
Up to 124 weeks
|
|
Change in RHS total score from baseline to week 24 of the double blinded treatment period (DBTP)
Tidsramme: Up to 24 weeks
|
The RHS (Revised Hammersmith Scale) is a validated 36-item scale developed to evaluate the spectrum of gross motor function. Maximum total score; 69 (optimal motor function) |
Up to 24 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline over time for the 6MWT - distance and fatigue index
Tidsramme: Up to 124 weeks
|
In the 6MWT (6-minute walk test) participants will be instructed to walk as fast as possible without jogging or running along a 25- meter linearly marked course for 6 minutes without using walking devices or assistance. Distance walked over the entire 6-minute period, and other parameters, will be determined |
Up to 124 weeks
|
|
ARGX-119 serum concentrations over time
Tidsramme: Up to 124 weeks
|
ARGX-119 serum concentrations over time |
Up to 124 weeks
|
|
Incidence of antidrug antibodies (ADA) against ARGX-119
Tidsramme: Up to 124 weeks
|
Incidence of antidrug antibodies (ADA) against ARGX-119 |
Up to 124 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- ARGX-119-24-SMA-2001
- 2025-523496-32-00 (Ctis)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .